-

Vertellus Completes Acquisition of IM Chemicals

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus, a manufacturer of specialty products for consumer goods, food & agriculture, healthcare, and industrial markets, today announced the completion of its acquisition of IM Chemicals, the intermediates and specialties division of ESIM Chemicals and a leading provider of specialty chemical products serving the pharmaceutical, coatings, and fuel & lubricant markets.

With the addition of IM Chemicals, Vertellus expands its specialty ingredients portfolio into new markets and bolsters its manufacturing capabilities in Europe. The combination strengthens Vertellus’ capability to serve its growing global customer base with market-leading specialty solutions and superior customer service.

John Van Hulle, CEO of Vertellus, said, “We are pleased to officially welcome IM Chemicals to the Vertellus family. I am confident that our shared commitment to customer satisfaction and product excellence will drive our growth and strengthen our position as a premier global provider of specialty ingredients and solutions.”

Indianapolis-based Vertellus is owned by Pritzker Private Capital and management.

About Vertellus

Headquartered in Indianapolis, the Vertellus group of companies was originally founded in 1857 as a manufacturer of niche specialty products. Today, Vertellus is one of the largest providers of unique specialty chemicals used in diverse applications, processes and market sectors, including personal care, healthcare, food & agriculture, performance coatings, paper additives, infrastructure, and industrial specialties. With 1,000+ employees, Vertellus serves customers across the globe from 10 international manufacturing facilities. Vertellus is a Responsible Care® company. For more information, visit vertellus.com.

About IM Chemicals

IM Chemicals is a leading producer of specialty anhydrides products used across a diverse group of end markets including coatings, pigments, construction and pharmaceutical. IM Chemicals operates a production site in Linz, Austria with more than 150 employees.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit www.ppcpartners.com.

Contacts

Abernathy MacGregor
Dan Scorpio
(312) 640-3111
dps@abmac.com

Vertellus


Release Versions

Contacts

Abernathy MacGregor
Dan Scorpio
(312) 640-3111
dps@abmac.com

More News From Vertellus

Aurorium Names Faye Freeman Chief Executive Officer

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, today announced that Faye Freeman, currently the company’s President, has been appointed Chief Executive Officer. Ms. Freeman, who joined Aurorium in 2019, will succeed John Van Hulle, who will transition to the role of Executive Chairman. “Faye is a fantastic leader with a proven track record of commercial and operational excellence,” said Mr. Van Hulle. “I’ve worked closely with her...

Aurorium Launches Haelium™ Pharmaceutical Solutions

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions. This new brand reflects Aurorium’s passion for and long-term commitment to healthcare. Built on decades of innovation, the Haelium product line unifies Aurorium as a global leader in pharmaceutical ingredients. Inspired by the Old English word “hælan," which meant “to cure,” “save,” or “make whole,” the Haelium br...

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus, a leading global supplier of high-performance solutions to the medical industry, is showcasing its range of Citroflex™ B6 phthalate free plasticizers, Biothane™ adhesives and sealants and PC Technology™-powered hemocompatible surface coatings at leading medical device expo MD&M West in Anaheim, Calif. Vertellus will be located at Booth 1289 at the Anaheim Convention Center from April 12 to April 14. “We look forward to sharing our high-quality speci...
Back to Newsroom